Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lifeward Ltd.RWLK · Entity 7620 | Director | September 13, 2023 | September 19, 2023 |
| REGENTIS BIOMATERIALS LTD.RGNT · Entity 7824 | Director | July 09, 2026 | July 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lifeward Ltd.
Report date September 13, 2023 · Filed September 19, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 0.25 per shareSEC Table I · non-derivative | IndirectESOP | 119,157 |
Reported balance
After 2023-09-13 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-09-13 · Grant · Acquired 59,595 · Balance 119,157 F1: Represents 59,595 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date. |
| Ordinary Shares, par value NIS 0.25 per shareSEC Table I · non-derivative | IndirectBy Partnership | 65,655 |
Reported balance
Holding disclosure · report date 2023-09-13 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 65,655 F2: Consists of 50,488 Ordinary Shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 Ordinary Shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 65,655 shares of ReWalk Robotics Ltd. |
| Ordinary Shares, par value NIS 0.25 per shareSEC Table I · non-derivative | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2023-09-13 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 50,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 59,595 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.
F2: Consists of 50,488 Ordinary Shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 Ordinary Shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 65,655 shares of ReWalk Robotics Ltd.
REGENTIS BIOMATERIALS LTD.
Report date July 09, 2026 · Filed July 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Warrants to purchase ordinary sharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2029-02-23 | Direct | 12,500 |
Reported balance
After 2026-07-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-09 · Grant · Acquired 12,500 · Balance 12,500 F1: This warrant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F2: The warrants are currently exercisable and have a three year term. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.16 · Expires 2036-05-28 | Direct | 24,826 |
Reported balance
After 2026-07-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-09 · Grant · Acquired 24,826 · Balance 24,826 F3: This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F4: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029. F5: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: This warrant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026.
F2: The warrants are currently exercisable and have a three year term.
F3: This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026.
F4: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029.
F5: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 09, 2026 Filed Jul 13, 2026 21:06 UTC | REGENTIS BIOMATERIALS LTD. RGNT · Entity 7824 | GrantEmployee Stock Option (Right to Buy) · Derivative | 24,826 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001213900-26-077633 · ownership.xml · derivative · entry 2 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,826 Underlying: Ordinary Shares · 24,826 shares Expires 2036-05-28 F3 · security: This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F4 · security: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029. F5 · security: To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2024 Share Option Plan must be registered in the name of a trustee. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 21:06 UTC | REGENTIS BIOMATERIALS LTD. RGNT · Entity 7824 | GrantWarrants to purchase ordinary shares · Derivative | 12,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-077633 · ownership.xml · derivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Ordinary Shares · 12,500 shares Expires 2029-02-23 F1 · security: This warrant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F2 · security: The warrants are currently exercisable and have a three year term. Read SEC document |
| September 13, 2023 Filed Sep 19, 2023 20:37 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 59,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-018263 · form4.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · ESOP Disclosed balance after: 119,157 F1 · shares: Represents 59,595 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 21:05 UTC | Lifeward Ltd. RWLK · Entity 7620 | PurchaseOrdinary Shares, par value NIS 0.25 per share | 10,000 | $0.62 | $6,150.00 |
DisclosureSEC source: 0001062993-23-016863 · form4.xml · nonDerivative · entry 2 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,162 F3 · shares: Represents Ordinary Shares purchased in the open market on August 17, 2023. F4 · price: The range in prices for the transaction reported on this line was $0.61 to $0.62. The average weighted price was $0.615. The reporting person will provide, upon request by the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 17, 2023 Filed Aug 29, 2023 12:36 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | PurchaseOrdinary Shares, par value NIS 0.25 per share | 10,000 | $0.62 | $6,150.00 |
DisclosureSEC source: 0001062993-23-017187 · form4a.xml · nonDerivative · entry 2 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 21:05 UTC | Lifeward Ltd. RWLK · Entity 7620 | PurchaseOrdinary Shares, par value NIS 0.25 per share | 15,000 | $0.60 | $9,045.00 |
DisclosureSEC source: 0001062993-23-016863 · form4.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,162 F1 · shares: Represents Ordinary Shares purchased in the open market on August 16, 2023. F2 · price: The range in prices for the transaction reported on this line was $0.597 to $0.61. The average weighted price was $0.603. The reporting person will provide, upon request by the Securities and Exchange Commission ("SEC"), the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| August 16, 2023 Filed Aug 29, 2023 12:36 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | PurchaseOrdinary Shares, par value NIS 0.25 per share | 15,000 | $0.60 | $9,045.00 |
DisclosureSEC source: 0001062993-23-017187 · form4a.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Read SEC document |
| August 02, 2022 Filed Aug 3, 2022 20:08 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-017170 · form4.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 50,000 F1 · shares: Represents 50,000 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 2, 2022 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the date of grant. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:05 UTC | Lifeward Ltd. RWLK · Entity 7620 | PurchaseOrdinary Shares, par value NIS 0.25 per share | 10,000 | $1.04 | $10,400.00 |
DisclosureSEC source: 0001062993-22-014549 · form4.xml · nonDerivative · entry 2 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,618 F3 · shares: Represents Ordinary Shares purchased in the open market on June 8, 2022. F4 · price: The range in prices for the transaction reported on this line was $1.03 to $1.04. The average weighted price was $1.04. The reporting person will provide, upon request by the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 08, 2022 Filed Jun 30, 2022 20:05 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | PurchaseOrdinary Shares, par value NIS 0.25 per share | 10,000 | $1.04 | $10,400.00 |
DisclosureSEC source: 0001062993-22-015670 · form4a.xml · nonDerivative · entry 2 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,162 F4 · shares: Represents Ordinary Shares purchased in the open market on June 8, 2022. F5 · price: The range in prices for the transaction reported on this line was $1.03 to $1.04. The average weighted price was $1.04. The reporting person will provide, upon request by the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:05 UTC | Lifeward Ltd. RWLK · Entity 7620 | PurchaseOrdinary Shares, par value NIS 0.25 per share | 15,000 | $1.00 | $15,000.00 |
DisclosureSEC source: 0001062993-22-014549 · form4.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,618 F1 · shares: Represents Ordinary Shares purchased in the open market on June 7, 2022. F2 · price: The range in prices for the transaction reported on this line was $1.00 to $1.01. The average weighted price was $1.00. The reporting person will provide, upon request by the Securities and Exchange Commission ("SEC"), the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| June 07, 2022 Filed Jun 30, 2022 20:05 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | PurchaseOrdinary Shares, par value NIS 0.25 per share | 15,000 | $1.00 | $15,000.00 |
DisclosureSEC source: 0001062993-22-015670 · form4a.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,162 F1 · date: This amendment is being filed to correct the number of shares directly and indirectly held by the reporting person. On July 7, 2020, the reporting person reported the acquisition of 10,948 Ordinary Shares underlying restricted stock units, which were granted to the reporting person on July 2, 2020 pursuant to the issuer's equity compensation plan. Such Ordinary Shares should have been reported as directly held, but due to an administrative error, such shares were mistakenly reported as indirectly held. See also footnote 6. F2 · shares: Represents Ordinary Shares purchased in the open market on June 7, 2022. F3 · price: The range in prices for the transaction reported on this line was $1.00 to $1.01. The average weighted price was $1.00. The reporting person will provide, upon request by the Securities and Exchange Commission ("SEC"), the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| May 21, 2022 Filed Jun 30, 2022 20:06 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 1,056 | $0.88 | $929.28 |
DisclosureSEC source: 0001062993-22-015671 · form4.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,162 F1 · shares: Represents Ordinary Shares sold in the open market on May 21, 2022, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain restricted stock units previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan. This Form 4 is being filed late due to an administrative error. F2 · price: Market price per share of ReWalk Robotics Ltd.'s (the "Company's") Ordinary Shares on the transaction date. F3 · balance_after: Prior to fiscal year 2020, the Reporting Person immediately and automatically assigned all Ordinary Shares underlying equity awards issued to the Reporting Person by the Company to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Ordinary Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Company with the permission of SCP. No Ordinary Shares were assigned to SCP by the Reporting Person after fiscal year 2019. This Form 4 reflects the Reporting Person's corrected direct and indirect beneficial ownership of Ordinary Shares as of May 21, 2022. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:30 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 1,100 | $1.10 | $1,210.00 |
DisclosureSEC source: 0001178913-22-000827 · zk2227368.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,618 F1 · shares: Represents Ordinary Shares sold in the open market on February 22, 2022, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain restricted stock units previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan. F2 · price: Market price per share of ReWalk Robotics Ltd.'s (the "Company's") Ordinary Shares on the transaction date. F3 · balance_after: Prior to fiscal year 2021, the Reporting Person immediately and automatically assigned all Ordinary Shares underlying equity awards issued to the Reporting Person by the Company to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Ordinary Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Company with the permission of SCP. No Ordinary Shares were assigned to SCP by the Reporting Person after fiscal year 2020. This Form 4 reflects the Reporting Person's corrected direct and indirect beneficial ownership of Ordinary Shares as of the filing date. Read SEC document |
| November 22, 2021 Filed Nov 23, 2021 13:30 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 1,100 | $1.35 | $1,485.00 |
DisclosureSEC source: 0001178913-21-003679 · zk2126879.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 77,373 F1 · shares: Represents Ordinary Shares sold in the open market on November 22, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · price: Market price per share of the Company's Ordinary Shares on the transaction date. F4 · balance_after: Based on filings made with the SEC, includes 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 55,874 ordinary shares of the Company Read SEC document |
| November 15, 2021 Filed Nov 19, 2021 21:06 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.25 per share | 4,129 | $1.53 | $6,317.37 |
DisclosureSEC source: 0001178913-21-003656 · zk2126869.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 78,473 F1 · shares: The disposed of securities consist of 2,480 ordinary shares sold by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares sold by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel") and 829 ordinary shares sold by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners D.C.M"). The shares were disposed of in connection with the termination of the funds. F2 · balance_after: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 55,874 ordinary shares of the Company. Read SEC document |
| August 23, 2021 Filed Aug 23, 2021 20:03 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 1,070 | $1.27 | $1,358.90 |
DisclosureSEC source: 0001178913-21-002812 · zk2126502.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 82,607 F1 · shares: Represents Ordinary Shares sold in the open market on August 23, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · price: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| July 20, 2021 Filed Jul 21, 2021 20:05 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 833 | $1.43 | $1,191.19 |
DisclosureSEC source: 0001178913-21-002334 · zk2126315.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 83,672 F1 · shares: Represents Ordinary Shares sold in the open market on July 20, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · price: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| May 21, 2021 Filed May 24, 2021 21:12 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001848 · zk2126084.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 91,450 F1 · shares: Represents 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 24, 2021 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company Read SEC document |
| May 21, 2021 Filed May 25, 2021 11:05 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001866 · zk2126100.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 91,450 F1 · shares: Represents 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 21, 2021 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company Read SEC document |
| May 21, 2021 Filed May 27, 2021 21:03 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 13,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001937 · zk2126118.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 84,505 F1 · shares: The Reporting Person is amending the Form 4 filed on May 24, 2021, as amended on May 25, 2021, which, due to an administrative error, inadvertently reported the grant on May 21, 2021 of 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The Reporting Person was actually granted 13,888 Ordinary Shares, issuable upon the vesting of RSUs. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company Read SEC document |
| April 05, 2021 Filed Apr 5, 2021 20:30 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 835 | $2.44 | $2,037.40 |
DisclosureSEC source: 0001178913-21-001288 · zk2125852.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 70,617 F1 · shares: Represents Ordinary Shares sold in the open market on April 05, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares when they were granted to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · price: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 12:12 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 840 | $1.36 | $1,142.40 |
DisclosureSEC source: 0001178913-21-000029 · zk2125326.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 71,452 F1 · shares: Represents Ordinary Shares sold in the open market on January 4, 2021, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · price: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| October 05, 2020 Filed Oct 5, 2020 20:05 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.25 per share | 840 | $1.08 | $907.20 |
DisclosureSEC source: 0001178913-20-002768 · zk2024966.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 72,292 F1 · shares: Represents Ordinary Shares sold in the open market on October 4, 2020, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:09 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 10,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001989 · zk2024591.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 73,132 F1 · shares: Represents 10,948 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company F3 · ownership.nature: Based on filings made with the SEC, consists of 40,707 ordinary shares beneficially owned by SCP Vitalife Partners II, L.P. ("SCP Vitalife Partners II"), a limited partnership organized in the Cayman Islands, 13,596 ordinary shares beneficially owned by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Partners Israel II"), a limited partnership organized in Israel, 2,480 ordinary shares beneficially owned by Vitalife Partners (Overseas) L.P. ("Vitalife Partners Overseas"), 820 ordinary shares beneficially owned by Vitalife Partners (Israel) L.P. ("Vitalife Partners Israel"), 829 ordinary shares beneficially owned by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM") and 1,571 ordinary shares held by the Israel Innovation Authority (the "IIA"), that Vitalife Partners Overseas, Vitalife Partners Israel and Vitalife Partners DCM have the right to acquire from IIA. The reporting person is therefore deemed to beneficially own 60,003 shares of the Company Read SEC document |
| March 30, 2020 Filed Apr 21, 2020 10:02 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 375 | $0.47 | $176.25 |
DisclosureSEC source: 0001178913-20-001149 · zk2024281.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 2,181 F1 · shares: Represents Ordinary Shares sold in the open market on March 30, 2020, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 20:32 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 3,252 | $2.16 | $7,024.32 |
DisclosureSEC source: 0001213900-20-000360 · doc4.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 2,556 F1 · shares: Represents Ordinary Shares sold in the open market on January 02, 2020, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 11:14 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 116,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-005033 · doc4.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 145,245 F1 · shares: Represents 116,496 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on March 27, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. F2 · shares: The Reporting Person immediately and automatically assigned these Ordinary Shares to SCP Vitalife II ("SCP") pursuant to the policies of SCP regarding Shares ownership by its employees, as documented by an Agreement between the Reporting Person and SCP. The Reporting Person is serving on the Board of the Issuer with the permission of SCP. F3 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
| April 30, 2018 Filed May 2, 2018 20:02 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 22,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001607962-18-000019 · wf-form4_152529128336891.xml · nonDerivative · entry 2 Dykan Jeff · CIK 0001661229 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 51,476 F1 · shares: Represents 22,727 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on April 30, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. Read SEC document |
| April 30, 2018 Filed May 2, 2018 20:02 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 22,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001607962-18-000019 · wf-form4_152529128336891.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 28,749 F1 · shares: Represents 22,727 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on April 30, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. Read SEC document |
| April 30, 2018 Filed Oct 15, 2018 13:16 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary shares, par value NIS 0.01 per share | 22,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-18-013895 · ownership.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 28,749 F1 · shares: The Reporting Person is amending the Form 4 filed on May 2, 2018, which, due to administrative error, inadvertently reported two grants of 22,727 ordinary shares, par value NIS per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs"). The Reporting Person received only one grant of such RSUs. The Reporting Person is also amending this Form 4 to file as an exhibit a signed authorization of the attorney-in-fact. F2 · shares: Represents 22,727 Ordinary Shares issuable upon the vesting of RSUs granted on April 30, 2018 under the ReWalk Robotics Ltd. 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 01:10 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 49,970 | $3.09 | $154,562.21 |
DisclosureSEC source: 0001144204-17-034725 · v469958_form4.xml · nonDerivative · entry 2 Dykan Jeff · CIK 0001661229 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By partnership Disclosed balance after: 1,500,100 F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016. F4 · shares: The disposed of securities consist of 37,459 Ordinary Shares sold by SCP Vitalife and 12,511 shares sold by SCP Vitalife Israel. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0000 to $3.2000, inclusive. The reporting person undertakes to provide to ReWalk Robotics, Ltd. ("ReWalk"), any security holder of ReWalk, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4. F3 · ownership.nature: The Reporting Person is a director of SCP Vitalife II GP, Ltd. ("SCP Vitalife GP"), which is the sole general partner of SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"). SCP Vitalife Associates is the sole general partner of each of SCP Vitalife and SCP Vitalife Israel, the direct beneficial owner of the Ordinary Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, except to the extent of his pecuniary interest therein. F6 · ownership.nature: As of June 27, 2017, SCP Vitalife Associates, as the general partner of SCP Vitalife and SCP Vitalife Israel, may be deemed to beneficially own 1,357,574 Ordinary Shares, which consist of 1,017,674 and 339,900 Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, respectively. SCP Vitalife GP is the general partner of SCP Vitalife Associates and, as such, shares voting and dispositive power over, and may be deemed to beneficially own, the Ordinary Shares held by the foregoing entities. The Reporting Person shares voting and dispositive power over, and may be deemed to beneficially own 1,500,100 Ordinary Shares, which consist of the Ordinary Shares as set forth in footnote (7) to this Form 4. F7 · ownership.nature: As of June 27, 2017, consists of 1,357,574 Ordinary Shares held by the foregoing entities due to the Reporting Person serving as a director of SCP Vitalife GP, as well as (i) 62,006 Ordinary Shares held by Vitalife Partners (Overseas) L.P., (ii) 20,506 Ordinary Shares held by Vitalife Partners (Israel) L.P., (iii) 20,733 Ordinary Shares held by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM", and together with Vitalife Partners (Overseas) L.P. and Vitalife Partners (Israel) L.P., the "Vitalife I Entities") and (iv) 39,281 Ordinary Shares currently held by the Office of the Chief Scientist of the State of Israel ("OCS"), that the Vitalife I Entities have the right to acquire from the OCS, due to the Reporting Person serving as a director of Vitalife Life Sciences Ltd., the general partner of Vitalife Partners Management L.P., which is the general partner of each of the Vitalife I Entities. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 12:43 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (Right to buy) · Derivative | 4,176 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001628280-17-006797 · wf-form4_149874017052740.xml · derivative · entry 1 Dykan Jeff · CIK 0001661229 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,176 Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares Expires 2027-06-27 F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant. Read SEC document |
| June 26, 2017 Filed Jun 29, 2017 01:10 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 37,030 | $3.00 | $111,090.00 |
DisclosureSEC source: 0001144204-17-034725 · v469958_form4.xml · nonDerivative · entry 1 Dykan Jeff · CIK 0001661229 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By partnership Disclosed balance after: 1,550,070 F1 · kind: Transaction made pursuant to a Rule 10b5-1 trading plan adopted December 15, 2016. F2 · shares: The disposed of securities consist of 27,759 Ordinary Shares sold by SCP Vitalife Partners II, L.P. ("SCP Vitalife") and 9,271 shares sold by SCP Vitalife Partners (Israel) II, L.P. ("SCP Vitalife Israel"). F3 · ownership.nature: The Reporting Person is a director of SCP Vitalife II GP, Ltd. ("SCP Vitalife GP"), which is the sole general partner of SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"). SCP Vitalife Associates is the sole general partner of each of SCP Vitalife and SCP Vitalife Israel, the direct beneficial owner of the Ordinary Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.